Horseradish peroxidase-labeled rabbit anti-non-structural protein 1 of dengue virus-2 for the diagnosis of dengue virus infections
BACKGROUND Early diagnosis of dengue virus (DENV) infection is essential for patient management and disease control. Detection of the antigen non-structural protein 1 (NS1) has been proven to provide early diagnosis of DENV infection. Thus, commercial NS1 antigen detection assays have been increasingly used and are becoming the
tool of choice among clinicians to confirm DENV infection in Indonesia.
METHODS To obtain anti-NS1 DENV antibody, NS1 protein (90 Âµg/ml) from the collection of the Department of Microbiology, Faculty of Medicine, Universitas Indonesia was injected into a rabbit. The anti-NS1 antibody from the rabbit was then labeled with horseradish peroxidase (HRP) using the periodate oxidation method. Sera were tested by enzyme-linked immunosorbent assay (ELISA) to detect NS1 from DENV-infected patients.
RESULTS Serially diluted antibody labeled with HRP tested using the direct ELISA method showed the highest absorbance value at a 1:100 dilution (Mean [SD] = 1.35 [0.35]); even at a dilution as high as 1:3,200 (0.22 [0.15]), antibody labeled with HRP was able to detect the NS1 protein, although the absorbance value did not differ greatly from that of the negative control (0.13 [0.01]).
CONCLUSIONS In an attempt to develop an NS1-based diagnostic test, polyclonal anti-NS1 DENV antibody was successfully produced as a diagnostic assay to determine the presence of DENV NS1 antigen in patientsâ€™ sera.
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16. https://doi.org/10.1038/nrmicro2460
Halstead SB. Dengue. Lancet. 2007;370(9599):1644-55. https://doi.org/10.1016/S0140-6736(07)61687-0
Idrees S, Ashfaq U. A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genet Vaccines Ther. 2012;10(1):6. https://doi.org/10.1186/1479-0556-10-6
Fatima Z, Idrees M, Bajwa MA, Tahir Z, Ullah O, Zia MQ, et al. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol. 2011;11:200. https://doi.org/10.1186/1471-2180-11-200
World Health Organization (WHO). Global Strategy for Dengue Prevention and Control. Geneva, Switzerland; WHO: 2012.
Anderson NW, Jespersen DJ, Rollins L, Seaton B, Prince HE, Theel ES. Detection of the dengue virus NS1 antigen using enzyme immunoasaay. Diagn Microbiol Infect Dis. 2014;79(2):194-7. https://doi.org/10.1016/j.diagmicrobio.2014.02.001
Wang SM, Sekaran SD. Evaluation of a commercial SD dengue virus NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J Clin Microbiol. 2010;48(8):2793-7. https://doi.org/10.1128/JCM.02142-09
Kassim FM, Izati MN, TgRogayah TA, Apandi YM, Saat Z. Use of dengue NS1 antigen for early diagnosis of dengue virus infection. Southeast Asian J Trop Med Public Health. 2011;42(3):562-9.
Hussain A, Rehman SU, Aslam S, Javed N, Abbas Z. Nano-gold particles mediated detection of NS1: an early diagnostic marker of dengue virus infection. J Anim Plant Sci. 2014;24(4):1110-5.
Pelling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, et al. Evaluation of diagnostic tests: dengue. Nature Rev Microbiol. 2010;8(12 Suppl):S30-8. https://doi.org/10.1038/nrmicro2459
World Health Organization (WHO). Dengue haemorrhagic fever, treatment, prevention and control. 2nd Ed. Geneva, WHO. 2009.
Dewi BE, Naiggolan L, Putri DH, Rachmayanti N, Albar S, Indriastuti NT, et al. Characterization of dengue virus serotype 4 infection in Jakarta, Indonesia. Southeast Asian J Trop Med Public Health. 2014;45(1):53-61.
Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis. 2013;7(7):e2311. https://doi.org/10.1371/journal.pntd.0002311
Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002;40(2):376-81. https://doi.org/10.1128/JCM.40.02.376-381.2002
Ramesh Kumar K, Xiavour S, Latha S, Kumar V, Sukumaran. Anti-human IgG-horseradish peroxidase conjugate preparation and its use in ELISA and Western blotting experiments. J Chromatograph Separat Techniq. 2014;5(1):211. https://doi.org/10.4172/2157-7064.1000211
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181(1):2-9. https://doi.org/10.1086/315215
Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study or dengue virus infection: correlation of results with those of the plaque reduction neutralization test. J Clin Microbiol. 2002;40(5):1840-44. https://doi.org/10.1128/JCM.40.5.1840-1844.2002
Chuang YC, Wang SY, Lin YS, Chen HR, Yeh TM. Re-evaluation of the pathogenic roles of nonstructural protein 1 and antibodies during dengue virus infection. J Biomed Sci. 2013;20:42. https://doi.org/10.1186/1423-0127-20-42
Muller DA, Young PR. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 2013;98(2):192-208. https://doi.org/10.1016/j.antiviral.2013.03.008
Huang JL, Huang JH, Shyu RH, Teng CW, Lin YL, Kuo MD, et al. High-level expression of recombinant dengue viral NS-1 protein and its potential uses as a diagnostic antigen. J Med Virol. 2001;65(3):553-60. https://doi.org/10.1002/jmv.2072
Qiu LW, Di B, Wen K, Wang XS, Liang WH, Wang YD, et al. Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections. Clin Vaccine Immunol. 2009;16(1):88-95. https://doi.org/10.1128/CVI.00212-08
Leenaars M, Hendriksen CF. Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations. ILAR J. 2005;46(3):269-79. https://doi.org/10.1093/ilar.46.3.269
Ray S, Das N, Bishayi B. Development of a simple method for a new immunoconjugate utilizing laccase. Research Journal of Immunology. 2012;5(1):1-16. https://doi.org/10.3923/rji.2012.1.16
Falconar AK. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol. 2007;14(5):493-504. https://doi.org/10.1128/CVI.00371-06
Falconar AK. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines. Clin Vaccine Immunol. 2008;15(3):549-61. https://doi.org/10.1128/CVI.00351-07
Wu HC, Huang YL, Chao TT, Jan JT, Huang JL, Chiang HY, et al. Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol. 2001;39(3):977-82. https://doi.org/10.1128/JCM.39.3.977-982.2001
Copyright (c) 2019 Evy Suryani Arodes, Beti Ernawati Dewi, Tjahjani Mirawati Sudiro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.